Study of the Efficacy and Safety of Nebivolol in Younger Patients (18 - 54 Years)

PHASE4CompletedINTERVENTIONAL
Enrollment

641

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

April 30, 2012

Conditions
Hypertension
Interventions
DRUG

Nebivolol

Nebivolol (non-trade 5, 10 or 20 mg tablet), oral administration

DRUG

Placebo

Dose-match placebo

Trial Locations (75)

19335

Forest Investigative Site 056, Downingtown

21093

Forest Investigative Site 008, Lutherville

23502

Forest Investigative Site 063, Norfolk

Forest Investigative Site 064, Norfolk

27103

Forest Investigative Site 036, Winston-Salem

27203

Forest Investigative Site 003, Asheboro

27609

Forest Investigative Site 014, Elizabeth

Forest Investigative Site 011, Raleigh

Forest Investigative Site 016, Raleigh

28277

Forest Investigative Site 010, Charlotte

28401

Forest Investigative Site 005, Wilmington

29669

Forest Investigative Site 022, Pelzer

30084

Forest Investigative Site 009, Atlanta

32765

Forest Investigative Site 045, Oviedo

32779

Forest Investigative Site 044, Longwood

33009

Forest Investigative Site 006, Hallandale

33014

Forest Investigative Site 001, Miami

Forest Investigative Site 012, Miami

Forest Investigative Site 032, Miami

Forest Investigative Site 055, Miami

33306

Forest Investigative Site 033, Fort Lauderdale

33709

Forest Investigative Site 031, St. Petersburg

Forest Investigative Site 030, Portland

34601

Forest Investigative Site 059, Brooksville

38654

Forest Investigative Site 035, Olive Branch

39038

Forest Investigative Site 038, Belzoni

40213

Forest Investigative Site 029, Louisville

42431

Forest Investigative Site 068, Madisonville

43213

Forest Investigative Site 002, Columbus

47630

Forest Investigative Site 069, Newburgh

47713

Forest Investigative Site 072, Evansville

49079

Forest Investigative Site 075, Paw Paw

55318

Forest Investigative Site 017, Chaska

55430

Forest Investigative Site 019, Brooklyn Center

60611

Forest Investigative Site 007, Chicago

61550

Forest Investigative Site 004, Morton

67010

Forest Investigative Site 025, Augusta

70005

Forest Investigative Site 061, Metairie

70119

Forest Investigative Site 057, New Orleans

Forest Investigative Site 058, New Orleans

73069

Forest Investigative Site 050, Norman

75234

Forest Investigative Site 037, Dallas

77081

Forest Investigative Site 015, Houston

Forest Investigative Site 026, Houston

Forest Investigative Site 027, Houston

Forest Investigative Site 074, Houston

77701

Forest Investigative Site 053, Beaumont

78006

Forest Investigative Site 066, Boerne

78404

Forest Investigative Site 076, Corpus Christi

80220

Forest Investigative Site 028, Denver

84058

Forest Investigative Site 071, Orem

84070

Forest Investigative Site 043, Haltom City

Forest Investigative Site 042, Sandy City

85014

Forest Investigative Site 065, Phoenix

Forest Investigative Site 067, Phoenix

Forest Investigative Site 070, Phoenix

89101

Forest Investigative Site 023, Las Vegas

Forest Investigative Site 048, Las Vegas

Forest Investigative Site 052, Las Vegas

90057

Forest Investigative Site 073, Los Angeles

90620

Forest Investigative Site 049, Buena Park

91505

Forest Investigative Site 034, Burbank

91942

Forest Investigative Site 047, La Mesa

91978

Forest Investigative Site 018, Spring Valley

92404

Forest Investigative Site 060, San Bernardino

92626

Forest Investigative Site 039, Costa Mesa

92708

Forest Investigative Site 024, Fountain Valley

93726

Forest Investigative Site 020, Fresno

Forest Investigative Site 021, Fresno

94115

Forest Investigative Site 054, San Francisco

94904

Forest Investigative Site 040, Greenbrae

95661

Forest Investigative Site 077, Roseville

98366

Forest Investigative Site 046, Port Orchard

02702

Forest Investigative Site 062, Fall River

08611

Forest Investigative Site 051, Trenton

Sponsors
All Listed Sponsors
lead

Forest Laboratories

INDUSTRY

NCT01415531 - Study of the Efficacy and Safety of Nebivolol in Younger Patients (18 - 54 Years) | Biotech Hunter | Biotech Hunter